Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03505684
Other study ID # 02-2017-033
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 24, 2017
Est. completion date July 30, 2018

Study information

Verified date August 2018
Source Pusan National University Yangsan Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison of a randomized, double-blind, and control-group study for the effect of oral ingestion of collagen tripeptides derived from fish on dermal moistures and wrinkles body fat reduction in participants


Description:

The aim is to investigate the effect of oral ingestion of collagen tripeptides derived from fish on dermal moistures and wrinkles body fat reduction in participants by a randomized, double-blind, and control-group study.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date July 30, 2018
Est. primary completion date July 15, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria:

- > = 4 of Tewameter

Exclusion Criteria:

- Within the last 6 months, took skin surgery including cosmetic purpose

- Diabetic patients with poor glycemic control with a fasting blood glucose of 160 mg/dl or more

- Creatinine levels: more than twice the normal upper limit

- AST (GOT) or ALT (GPT) levels: more than twice the normal upper limit

- Uncontrolled hypertension

- sun allergy or sensitive skin

- functional cosmetics that affect dermal moistures and wrinkles within the last 3 months.

- If you have participated or are planning to participate in another clinical trial within the past month

- Alcohol abuser

- If they are pregnant or lactating or have a pregnancy plan during the clinical trial Those with allergic reactions to the constituent food

- Any person deemed inappropriate by the researcher for other reasons

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
CTP
1,000 mg of CTP was orally administered per day for 12 weeks.
placebo (starch)
placebo (starch)

Locations

Country Name City State
Korea, Republic of Integrated Research Institute for Natural Ingredients and Functional Foods Yangsan

Sponsors (1)

Lead Sponsor Collaborator
Pusan National University Yangsan Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary changes in Transepidermal Waterloss by Tewameter comparison between baseline, after 6 weeks, and after 12 weeks baseline, after 6 weeks, and after 12 weeks
Secondary changes in skin wrinkling indices by Visiometer comparison between baseline, after 6 weeks, and after 12 weeks baseline, after 6 weeks, and after 12 weeks
Secondary skin elasticity by Cutometer comparison between baseline, after 6 weeks, and after 12 weeks baseline, after 6 weeks, and after 12 weeks
Secondary changes in hydration level of the skin surface by Corneometer comparison between baseline, after 6 weeks, and after 12 weeks baseline, after 6 weeks, and after 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT05597254 - Facial Skin Clinical and Microbial Profiling From Oral Probiotic Supplementation N/A
Active, not recruiting NCT06140628 - A 28-day Clinical Study on Facial Skin Rejuvenation N/A
Completed NCT04154436 - Effectiveness, Safety, and Cost Efficacy of Water (H2O) as a Substitute for Sodium Bicarbonate (NaHCO3) Plus Solution in Neutralization of Chemical Peeling Using 35% Glycolic Acid Solution N/A
Withdrawn NCT02787356 - Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging N/A
Completed NCT04449159 - Efficacy of Vinh Wellness Collagen on Skin Health N/A
Enrolling by invitation NCT06188338 - A 56-day Clinical Study on Facial Skin Rejuvenation N/A
Completed NCT01139047 - Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin Phase 4
Completed NCT01139008 - Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin Phase 4
Completed NCT05094687 - Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).
Recruiting NCT05235997 - Placebo Controlled Efficacy Evaluation of the Hydrolyzed Collagen Peptide In Adult Females N/A
Completed NCT01046396 - Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin Phase 1
Completed NCT01046565 - Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin Phase 1
Completed NCT04701463 - A Specialized Amino Acid Mixture on Body Composition and Skin State in Overweight and Obese Class I Postmenopausal Women N/A
Completed NCT02422836 - Tolerability and Efficacy of Anti-Aging Treatment Regimen in Subjects With Photodamage N/A
Completed NCT04002856 - Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck N/A
Completed NCT03873896 - The Skin Wrinkle Test: a Simple Clinical Test of Regional Block Success N/A
Active, not recruiting NCT06152718 - New Regenerative Approach for Dermal Renovation (Karisma)
Recruiting NCT04344119 - Assessment of Chilbains Occuring During Covid-19 Infection
Recruiting NCT06291415 - The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) Phase 1
Completed NCT05872178 - Omegia Softgel Clinical Research Program N/A